scholarly journals Increased adult neurogenesis associated with reactive astrocytosis occurs prior to neuron loss in a mouse model of neurodegenerative disease

2017 ◽  
Vol 23 (11) ◽  
pp. 885-893 ◽  
Author(s):  
Ting-Ting Liu ◽  
Xiao-Lian Ye ◽  
Jin-Ping Zhang ◽  
Ting-Ting Yu ◽  
Shan-Shan Cheng ◽  
...  

2001 ◽  
Vol 24 (11) ◽  
pp. 1510-1519 ◽  
Author(s):  
Sandra J. Feeney ◽  
Penelope A. McKelvie ◽  
Lawrence Austin ◽  
M.J. Bernadette Jean-Francois ◽  
Robert Kapsa ◽  
...  


2006 ◽  
Vol 1 (1) ◽  
pp. 15-28 ◽  
Author(s):  
Barbara Steiner ◽  
Susanne A Wolf ◽  
Gerd Kempermann


PLoS ONE ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. e76497 ◽  
Author(s):  
Alice Krezymon ◽  
Kevin Richetin ◽  
Hélène Halley ◽  
Laurent Roybon ◽  
Jean-Michel Lassalle ◽  
...  


2021 ◽  
Vol 24 (12) ◽  
pp. 1640-1640
Author(s):  
Leonie Welberg


2021 ◽  
Vol 124 ◽  
pp. 105097
Author(s):  
Hoda Eliwa ◽  
Bruno Brizard ◽  
Anne-Marie Le Guisquet ◽  
René Hen ◽  
Catherine Belzung ◽  
...  


2020 ◽  
Vol 58 (1) ◽  
pp. 204-216
Author(s):  
Martina Stazi ◽  
Oliver Wirths

AbstractMemantine, a non-competitive NMDA receptor antagonist possessing neuroprotective properties, belongs to the small group of drugs which have been approved for the treatment of Alzheimer’s disease (AD). While several preclinical studies employing different transgenic AD mouse models have described beneficial effects with regard to rescued behavioral deficits or reduced amyloid plaque pathology, it is largely unknown whether memantine might have beneficial effects on neurodegeneration. In the current study, we assessed whether memantine treatment has an impact on hippocampal neuron loss and associated behavioral deficits in the Tg4-42 mouse model of AD. We demonstrate that a chronic oral memantine treatment for 4 months diminishes hippocampal CA1 neuron loss and rescues learning and memory performance in different behavioral paradigms, such as Morris water maze or a novel object recognition task. Cognitive benefits of chronic memantine treatment were accompanied by an amelioration of impaired adult hippocampal neurogenesis. Taken together, our results demonstrate that memantine successfully counteracts pathological alterations in a preclinical mouse model of AD.



PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0161341 ◽  
Author(s):  
Holly J. Garringer ◽  
Jose M. Irimia ◽  
Wei Li ◽  
Charles B. Goodwin ◽  
Briana Richine ◽  
...  


2004 ◽  
Vol 164 (4) ◽  
pp. 1495-1502 ◽  
Author(s):  
Christoph Schmitz ◽  
Bart P.F. Rutten ◽  
Andrea Pielen ◽  
Stephanie Schäfer ◽  
Oliver Wirths ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document